Pfizer Chairman and CEO Albert Bourla joined Frederick Kempe to discuss how artificial intelligence is transforming the healthcare industry. From drug discovery to clinical research and beyond, they explore the opportunities and challenges ahead. Bourla also addresses the role business and government play in ensuring innovation keeps pace with rapid technological advances. This conversation took place during the Atlantic Council’s #ACinNY programming on the sidelines of the United Nations General Assembly.